10 Best Cannabis Stocks to Buy According to Billionaires

7. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Billionaire Holders: 4

As a Canada-based medical cannabis company, Aurora Cannabis Inc. (NASDAQ:ACB) is focused on the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally and the propagation of vegetables and ornamental plants in North America. Since 2006, the company has developed more than 200 different medical products, transforming itself from a Canadian recreational player into an international medical cannabis powerhouse.

Aurora Cannabis Inc. (NASDAQ:ACB) had a strong Q3 2025, as its EPS of $0.41 overwhelmingly surpassed expectations by $0.42. The company generated a record net income of $31.2 million, up 282% YoY, and a record adjusted EBITDA of $23.1 million, up 316% YoY. Q3 revenue also surged by 28.73% YoY to $61.62 million, topping estimates, driven by all-time highs in global medical net revenue. Aurora’s globalization strategy is paying off, and within global medical cannabis, its international revenue increased by 112%. For the second consecutive quarter, international revenue surpassed Canadian medical cannabis. ACB also generated $27.4 million of free cash flow in the third quarter of 2025. The company maintains a robust balance sheet and ended the quarter with $180.2 million in cash and cash equivalents and no cannabis business debt.

Aurora Cannabis Inc. (NASDAQ:ACB) maintains a world-class research and genetics facility in Canada, setting new standards in cannabis science. The company recently announced the discovery of a novel source of genetic resistance against powdery mildew that provides strong protection against this pathogen in cannabis sativa. The development offers a critical solution to a pressing challenge in the cannabis industry worldwide and is now in use in Aurora’s breeding program.